Loading market dashboard
Auna S.A.
AUNAHealthcareNYSELU
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
Auna trades at depressed valuations despite a stable, integrated insurance and hospital business spanning Peru, Colombia, and Mexico. Operational setbacks in Mexico and Colombia have pressured results, but recent management actions and Q1 trends indicate stabilization and recovery potential. AUNA's leverage remains high (net debt/EBITDA 3.7x), but recent debt restructuring, improved cash generation, and reduced capex support deleveraging.
Auna S.A. (AUNA) Q1 2026 Earnings Call Transcript
Auna's Q1 2026 EPS misses expectations as margins tighten despite 18.7% revenue growth; shares fall 2.7% in after-hours trading.
Auna NYSE: AUNA reported stronger first-quarter revenue and cash flow across its regional healthcare platform, while adjusted EBITDA declined as the company absorbed revenue adjustments in Peru and higher payroll costs in Mexico and Colombia.
Auna S.A. (AUNA) came out with quarterly earnings of $0.05 per share, missing the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.19 per share a year ago.
LUXEMBOURG--(BUSINESS WIRE)--Auna (NYSE: AUNA) (“Auna” or the “Company”), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, announced today financial results for the first quarter ended March 31, 2026 (“first quarter 2026” or “1Q26”). Financial results are expressed in Peruvian Soles (“S/” or “PEN” or “Soles”) and are presented in accordance with International Financial Reporting Standards (“IFRS”), unless otherwise noted. 1Q'26 Consolidated Highlight.
Auna S.A. (AUNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AUNA S.A. heads into May 19 Q1 results with a flat EPS outlook and 8%+ revenue growth expected, but weak signals from Mexico and mixed regional trends cloud sentiment.
Auna S.A. (AUNA) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
AUNA eyes 12% EBITDA growth by 2026 as Mexico stabilizes, refinancing cuts costs, and hospital network gains boost demand across key markets.
Auna S.A. gains from Peru growth, stabilizing Mexico and Colombia cash flow focus, while Surgery Partners faces earnings cuts and headwinds.
LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (“Auna” or the “Company”) (NYSE: AUNA), a Latin American healthcare company with operations in Mexico, Peru and Colombia, announced today the filing of its Annual Report on Form 20-F for the fiscal year ended December 31, 2025, with the Securities and Exchange Commission (the “SEC”) on April, 21, 2026. Auna's Annual Report on Form 20-F can be accessed by visiting either the SEC's website at www.sec.gov or the “Financial Info” section of the Company's Inves.
AUNA advances oncology push in Mexico with new Oncocenter, insurer tie-ups, and rising revenues, signaling strong traction in a key growth market.
LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA) (“Auna” or the “Company”), a leading healthcare services platform in Latin America with operations in Mexico, Peru, and Colombia, today reported select operating metrics for the First Quarter ended March 31, 2026. The Company intends to publish these key performance indicators on a quarterly basis going forward, as part of its commitment to providing investors with more information and a clearer understanding of Auna. Preliminary Key Performan.
LUXEMBOURG--(BUSINESS WIRE)--Auna S.A. (NYSE: AUNA) (“Auna” or “the Company”), a leading Latin American healthcare services and plan provider with operations in Mexico, Peru and Colombia, announced today the reporting dates for its First Quarter 2026 financial results. Earnings Release Tuesday, May 19, 2026 Time: After Market Close Conference Call Wednesday, May 20, 2026 Time: 8:00 a.m. ET Quiet Period Monday, May 4 through Tuesday May 19, 2026 To participate, please dial +1 888 596 4144 (Toll-.
AUNA S.A. rallies as Peru delivers steady growth, Mexico shows turnaround signs, and improved liquidity and cash flow boost confidence in its outlook.
AUNA leans on risk-sharing models in Colombia, boosting revenues and cash flow while reducing exposure to government-intervened payors.
Auna S.A. (NYSE: AUNA - Get Free Report) has been given an average recommendation of "Hold" by the five analysts that are currently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell recommendation, two have issued a hold recommendation, one has issued a buy recommendation and one has given a strong
Auna (NYSE: AUNA - Get Free Report) and SeaStar Medical (NASDAQ: ICU - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, profitability, dividends, analyst recommendations, valuation, risk and institutional ownership. Analyst Ratings This is a breakdown of current
Here is how Auna S.A. (AUNA) and Brookdale Senior Living (BKD) have performed compared to their sector so far this year.
Auna S.A.'s strong Peru results, Mexico recovery and improved cash flow make it a compelling ambulatory care pick over THC.
Auna (NYSE: AUNA - Get Free Report) and Todos Med (OTCMKTS:TOMDF - Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, profitability, earnings, dividends, valuation, risk and analyst recommendations. Risk and Volatility Auna has a beta of 2.09,
AUNA rallies after Q4 as Peru growth, Mexico recovery signals, and rising cash flow strengthen its outlook and balance sheet.
AUNA holds leverage at 3.6X but targets sub-3X, backed by rising free cash flow, refinancing moves and improving Mexico performance.
AUNA's Peru operations shine with double-digit revenue and EBITDA growth, driven by high-complexity care and expanded health plan reach.
Here is how Auna S.A. (AUNA) and Brookdale Senior Living (BKD) have performed compared to their sector so far this year.
AUNA's Mexico operations witness Q4 stabilization as oncology revenues jump 35% sequentially, and new insurer and ISSSTELEON deals position the business for 2026 growth.
Auna S.A. (AUNA) Q4 2025 Earnings Call Transcript
AUNA, ARW and DECK made it to the Zacks Rank #1 (Strong Buy) value stocks list on March 11th, 2026.
Auna S.A. (AUNA) came out with quarterly earnings of $0.53 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.12 per share a year ago.
LUXEMBOURG--(BUSINESS WIRE)--Auna (NYSE: AUNA) (“Auna” or the “Company”), a leading healthcare platform in Latin America with operations in Mexico, Peru, and Colombia, announced today financial results for the fourth quarter ended December 31, 2025 (“fourth quarter 2025” or “4Q25”) and full-year ended 2025 (“full-year 2025” or “FY25”). Financial results are expressed in Peruvian Soles (“S/” or “PEN”) and are presented in accordance with International Financial Reporting Standards (“IFRS”), unle.
Auna S.A. (AUNA) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Shares of Auna S.A. (NYSE: AUNA - Get Free Report) have earned an average recommendation of "Moderate Buy" from the five research firms that are covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, one has given a hold recommendation, one has given a buy recommendation and two have given
